Abstract
Sanghuangporus spp. are medicinal fungi with significant therapeutic value, but their taxonomic ambiguity and frequent market adulteration have hindered their standardized utilization. In this study, untargeted metabolomics based on UPLC-Q-TOF-MS was employed to systematically analyze the metabolic profiles of three Sanghuangporus species: Sanghuangporus. sanghuang (SS), Sanghuangporus. vaninii (SV), and Sanghuangporus. baumii (SB). A total of 788 metabolites were identified and classified into 16 categories, among which 97 were common differential metabolites, including bioactive compounds such as flavonoids, polysaccharides, and terpenoids. Multivariate statistical analyses (PCA and OPLS-DA) revealed distinct metabolic patterns among the species. KEGG pathway enrichment analysis showed that the differential metabolites were mainly involved in flavonoid and isoflavonoid biosynthesis. Notably, SV and SB exhibited significantly higher levels of several key bioactive compounds, including Apigenin and D-glucuronolactone, compared to SS. These findings highlight substantial interspecies differences in metabolic composition and pharmacological potential, providing a scientific basis for species authentication, quality control, and medicinal development of Sanghuangporus.